JIS and IEC Electrical Safety and EMC Testing for Japan
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Electrical medical devices entering Japan cannot assume that IEC reports can directly substitute for JIS testing. Japan’s grid voltage is 100V, and the JIS T 0601 series contains Japan-specific national deviations when it corresponds to the IEC 60601 series. GRZAN recommends building a standards deviation ledger at the test plan design stage, rather than arranging supplementary tests after the IEC reports are already in hand — the schedule cost of the latter approach usually exceeds that of confirming the deviations at the very beginning. Early deviation confirmation turns the standards question into a planned work item; late discovery turns it into a retest campaign.
- The certification standards and the Essential Principles directly designate the Japanese industrial standards that must be applied; the answer to whether JIS testing is needed is written in the standards themselves.
- Japan’s distribution voltage is 100V, with both 50Hz and 60Hz frequencies; test conditions must be set according to Japanese use conditions.
- Covering the Japanese conditions with 230V results taken from IEC reports is generally not accepted.
- National deviations differ in content and number from fascicle to fascicle, so deviations must be confirmed item by item, not judged by standard family.
- Version years of cited JIS standards are pending verification and must be confirmed against the current publications of the Japanese Industrial Standards Committee.
2. Legal basis
The applicable standards for electrical medical devices are fixed by the statutory benchmarks under the PMD Act and by the design control requirements of the QMS Ordinance. The key sources are as follows.
- PMD Act Article 41, Paragraph 3: the Essential Principles — benchmarks established by the Minister of Health, Labour and Welfare for medical devices.
- PMD Act Article 42, Paragraph 2: the certification standards — benchmarks applicable under the certification route.
- PMD Act Article 23-2-5, Paragraph 2: the judgment of quality, efficacy and safety in approval review.
- JIS T 0601 series (the Japanese industrial standards corresponding to the IEC 60601 series); the EMC portion corresponds to the electromagnetic compatibility fascicle within the JIS T 0601-1 series — the specific version years are pending verification and should be confirmed against the current publications of the Japanese Industrial Standards Committee.
- QMS Ordinance (MHLW Ordinance No. 169 of 2004): requirements for records of the application of standards in the design and development process.
- Current statute: Act No. 145 of 1960.
3. Expert insights
Insight 1: The certification standards and the Essential Principles directly designate the applicable Japanese industrial standards.
Within the benchmarks authorized by Article 41, Paragraph 3 and Article 42, Paragraph 2, specific JIS standards are frequently cited directly. The answer to the question of whether JIS testing is required therefore lies inside the benchmarks, not in industry custom. This changes how the standards question should be approached: before planning any testing, obtain the certification standards or Essential Principles entries applicable to the target product and read exactly which JIS standards and which versions they cite. A test plan built on the cited standards is aligned with the statutory requirements from the start, and the reviewer’s conformity judgment can proceed without a debate about which standards should have applied.
Insight 2: The 100V grid is not just a voltage figure — it drives the design verification of the whole device.
Japan’s distribution voltage is 100V, and the frequency comes in two forms, 50Hz and 60Hz. The voltage adaptation of electrical devices, the verification of power consumption, and the test conditions for protective actions all need to be set according to Japanese use conditions. Attempting to cover these conditions directly with 230V results taken from an IEC report is generally not accepted. The consequence reaches beyond electrical safety into design verification as a whole: a device designed and verified only for European conditions may need design-level work, not just additional testing, to demonstrate conformity in Japan. Identifying this at the design stage is materially cheaper than discovering it after verification reports have been finalized.
Insight 3: Deviation items must be confirmed one by one; they cannot be judged broadly by standard family.
Even within the JIS T 0601 series, the content and the number of Japanese national deviations differ from fascicle to fascicle. Companies should list the deviations item by item against the specific fascicles applicable to the target product, forming a deviation explanation table that can be submitted for review. A blanket statement that the JIS series roughly matches the IEC series tells the reviewer nothing and invites questions. The deviation table, by contrast, becomes part of the evidence: it shows which clauses were tested under Japanese conditions, which were satisfied by the IEC report, and why each treatment is acceptable for this product.
4. Practical recommendations
- Build the standards deviation ledger at the test plan stage. Fields should include: the applicable JIS number, the corresponding IEC number, the deviation content, and whether it has been covered in the verification of this product.
- Set the test conditions according to Japanese use conditions. The conditions of 100V and 50/60Hz should be clearly recorded in the test reports.
- Under the certification route, check the cited standards of the certification standards first. Verify against whichever JIS version the benchmark cites.
- Set up the EMC fascicle as a separate work item. The Japanese deviations of the electromagnetic compatibility requirements usually need a separate test arrangement.
5. Verification checklist
- □ Have the certification standards or Essential Principles applicable to the target product been obtained, and the cited JIS standards checked?
- □ Have the test conditions been set to 100V and 50/60Hz?
- □ Does the standards deviation ledger list deviations fascicle by fascicle, rather than judging broadly by standard family?
- □ Has a separate test arrangement been made for the EMC-related fascicles?
- □ Have the version years of the cited JIS standards been confirmed in the current publication information of the Japanese Industrial Standards Committee?
Legal information verified as of October 29, 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, in-country representative and local testing support for the Japanese market. Our team prepares J-GCP/J-QMS compliant dossiers, coordinates conformity assessments, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us